Which statement describes renal osteodystrophy?

• A. Bone disease due to vitamin D excess only
• B. Bone tumors caused by calcium overload
• C. Bone density increases with CKD
• D. A bone disorder resulting from secondary hyperparathyroidism due to CKD

Answer: (D)

Renal osteodystrophy is a bone disorder that arises from chronic kidney disease due to disturbances in mineral metabolism, especially secondary hyperparathyroidism. In CKD, the kidneys don’t excrete phosphate well and can’t activate vitamin D effectively, leading to phosphate buildup and reduced calcium absorption. The resulting low calcium triggers the parathyroid glands to release more PTH, a response known as secondary hyperparathyroidism. This hormone increases bone turnover and resorption to raise serum calcium, causing bone weakening, deformities, and a higher fracture risk—the spectrum of bone changes seen with CKD.

That’s why the statement describing renal osteodystrophy as a bone disorder resulting from secondary hyperparathyroidism due to CKD is the best answer. The other options don’t fit: excess vitamin D isn’t the driver here ( vitamin D is deficient in CKD ); bone tumors from calcium overload aren’t the mechanism; CKD-related bone disease does not typically involve increased bone density—it's characterized by abnormal bone remodeling and loss rather to increased density.